Biogen Inc (BIIB)
NASDAQ · Healthcare · Drug Manufacturers - General
Biogen Inc is a Healthcare company with a market capitalization of $31.25B and a trailing P/E ratio of 37.5.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $3.57 | $2.89 | +23.5% |
| Q4 2025 | February 6, 2026 | $1.99 | $1.62 | +22.8% |
| Q3 2025 | October 30, 2025 | $4.81 | $3.88 | +24.0% |
| Q2 2025 | July 31, 2025 | $5.47 | $3.88 | +41.0% |
| Q1 2025 | May 1, 2025 | $3.02 | $2.95 | +2.4% |
| Q4 2024 | February 12, 2025 | $3.44 | $3.36 | +2.4% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 5,999,133 | 4.04% | 3.5 | +4.8% |
| June 30, 2026 | 5,723,194 | 3.86% | 4.1 | +10.3% |
| June 15, 2026 | 5,188,836 | 3.50% | 5.7 | +8.8% |
| May 29, 2026 | 4,771,495 | 3.22% | 4.5 | +0.9% |
| May 15, 2026 | 4,729,958 | 3.19% | 4.2 | +5.7% |
| April 30, 2026 | 4,475,470 | 3.02% | 3.6 | +1.4% |
| April 15, 2026 | 4,414,958 | 3.01% | 3.1 | +15.4% |
| March 31, 2026 | 3,826,441 | 2.61% | 3.5 | -11.7% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Biogen Inc's market cap?
As of August 13, 2026, Biogen Inc (BIIB) has a market capitalization of $31.25B.
What is Biogen Inc's P/E ratio?
Biogen Inc trades at a trailing price-to-earnings (P/E) ratio of 37.5. Its forward P/E is 17.3.
Does Biogen Inc pay a dividend?
Biogen Inc does not currently pay a dividend.
What sector is BIIB in?
Biogen Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Biogen Inc's short interest?
As of the July 15, 2026 FINRA settlement, 5,999,133 BIIB shares were sold short, or 4.04% of shares outstanding. Days to cover: 3.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Biogen Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Biogen Inc reported revenue of $9.81B and net income of $1.29B.
Ask your own questions about BIIB
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.